Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research.

MLA

Schnell, Oliver, et al. “Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research.” Diabetes Care, vol. 38, no. 9, Sept. 2015, pp. 1627–33. EBSCOhost, https://doi.org/10.2337/dc14-2919.

APA

Schnell, O., Barnard, K., Bergenstal, R., Bosi, E., Garg, S., Guerci, B., Haak, T., Hirsch, I. B., Ji, L., Joshi, S. R., Kamp, M., Laffel, L., Mathieu, C., Polonsky, W. H., Snoek, F., & Home, P. (2015). Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research. Diabetes Care, 38(9), 1627–1633. https://doi.org/10.2337/dc14-2919

Chicago

Schnell, Oliver, Katharine Barnard, Richard Bergenstal, Emanuele Bosi, Satish Garg, Bruno Guerci, Thomas Haak, et al. 2015. “Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research.” Diabetes Care 38 (9): 1627–33. doi:10.2337/dc14-2919.